T cell epitopes are largely conserved in the SARS-CoV-2 Omicron subvariant (BA.1, BA.2, BA.3, and GKA).
作者信息
Li Hu, Chen Zhiwei, Liu Xiaoqing, Hu Peng
机构信息
Department of Infectious Diseases, Institute for Viral Hepatitis, The Key Laboratory of Molecular Biology for Infectious Diseases, Chinese Ministry of Education, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
出版信息
J Med Virol. 2022 Oct;94(10):4591-4592. doi: 10.1002/jmv.27925. Epub 2022 Jun 16.
Abstract
摘要
相似文献
1
T cell epitopes are largely conserved in the SARS-CoV-2 Omicron subvariant (BA.1, BA.2, BA.3, and GKA).T细胞表位在新冠病毒奥密克戎亚变体（BA.1、BA.2、BA.3和GKA）中基本保守。
J Med Virol. 2022 Oct;94(10):4591-4592. doi: 10.1002/jmv.27925. Epub 2022 Jun 16.
2
SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals.新冠病毒奥密克戎变异株 BA.4/BA.5 刺突突变导致近期接种疫苗个体 T 细胞逃逸。
Viruses. 2022 Dec 29;15(1):101. doi: 10.3390/v15010101.
3
Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.奥密克戎 BA.1 突变使 SARS-CoV-2 刺突蛋白减少，导致接种疫苗和康复个体的 T 细胞反应降低。
Viruses. 2022 Jul 19;14(7):1570. doi: 10.3390/v14071570.
4
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity.奥密克戎亚谱系中保守的刺突蛋白中和抗体位点逐渐丧失，但 T 细胞免疫得以保留。
Cell Rep. 2023 Aug 29;42(8):112888. doi: 10.1016/j.celrep.2023.112888. Epub 2023 Jul 31.
5
Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1.疫苗衍生的 SARS-CoV-2 T 细胞反应对 BA.2.86 和 JN.1 的交叉反应性评估
Viruses. 2024 Mar 20;16(3):473. doi: 10.3390/v16030473.
6
A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population.SARS-CoV-2 变体中 T 细胞表位多样性的生物信息学分析：与美国人群中 COVID-19 临床严重程度的关联。
Front Immunol. 2024 May 9;15:1357731. doi: 10.3389/fimmu.2024.1357731. eCollection 2024.
7
Potential linear B-cells epitope change to a helix structure in the spike of Omicron 21L or BA.2 predicts increased SARS-CoV-2 antibodies evasion.奥密克戎 21L 或 BA.2 刺突蛋白中潜在的线性 B 细胞表位向螺旋结构的改变预示着 SARS-CoV-2 抗体逃避能力增强。
Virology. 2022 Aug;573:84-95. doi: 10.1016/j.virol.2022.06.010. Epub 2022 Jun 16.
8
Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice.奥密克戎变异株 BA.1 刺突突变对小鼠 T 细胞表位的影响。
Viruses. 2023 Mar 16;15(3):763. doi: 10.3390/v15030763.
9
SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate.SARS-CoV-2 奥密克戎变异株的刺突蛋白 N405 不太可能迅速脱酰胺。
Biochem Biophys Res Commun. 2023 Jul 23;666:61-67. doi: 10.1016/j.bbrc.2023.04.088. Epub 2023 May 2.
10
Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity.细胞表位景观显示逃避细胞免疫的 SARS-CoV-2 变体刺突的热点突变。
J Med Virol. 2024 Feb;96(2):e29452. doi: 10.1002/jmv.29452.
引用本文的文献
1
The trend of phylogenetic and epitope variations of SARS-CoV-2 Omicron sub-lineages in Iran.伊朗新冠病毒奥密克戎亚谱系的系统发育和表位变异趋势。
Front Microbiol. 2025 Jan 29;15:1531712. doi: 10.3389/fmicb.2024.1531712. eCollection 2024.
2
Neutralizing antibody and CD8 T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2.BA.4/5 二价 COVID-19 加强疫苗接种后对有和无 SARS-CoV-2 既往暴露的成年人的中和抗体和 CD8 T 细胞应答。
Front Immunol. 2024 Mar 20;15:1353353. doi: 10.3389/fimmu.2024.1353353. eCollection 2024.
3
Effects of SARS-CoV-2 Omicron BA.1 Spike Mutations on T-Cell Epitopes in Mice.奥密克戎变异株 BA.1 刺突突变对小鼠 T 细胞表位的影响。
Viruses. 2023 Mar 16;15(3):763. doi: 10.3390/v15030763.
4
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection.冠状病毒刺突蛋白中保守区域对研发抗SARS-CoV-2感染新型疫苗的意义
Vaccines (Basel). 2023 Feb 24;11(3):545. doi: 10.3390/vaccines11030545.
5
Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients.奥密克戎 BA.1 感染对移植受者中 BA.4/5 免疫的影响。
Am J Transplant. 2023 Feb;23(2):278-283. doi: 10.1016/j.ajt.2022.10.004. Epub 2023 Jan 12.
6
SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron.加拿大献血者中 SARS-CoV-2 血清流行率：奥密克戎的进展。
Viruses. 2022 Oct 25;14(11):2336. doi: 10.3390/v14112336.
本文引用的文献
1
Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination.SARS-CoV-2 Delta 和 Omicron 共感染和重组的证据。
Med. 2022 Dec 9;3(12):848-859.e4. doi: 10.1016/j.medj.2022.10.002. Epub 2022 Oct 20.
2
Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France.在法国南部的三例聚集性病例中培养并鉴定出一种“德尔塔-奥密克戎” SARS-CoV-2。
J Med Virol. 2022 Aug;94(8):3739-3749. doi: 10.1002/jmv.27789. Epub 2022 May 6.
3
T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）蛋白中的T细胞表位在奥密克戎变体中基本保守。
Cell Mol Immunol. 2022 Mar;19(3):447-448. doi: 10.1038/s41423-022-00838-5. Epub 2022 Jan 18.
4
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.南非 SARS-CoV-2 奥密克戎变异株的快速流行扩张。
Nature. 2022 Mar;603(7902):679-686. doi: 10.1038/s41586-022-04411-y. Epub 2022 Jan 7.
5
Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform.852 例 COVID-19 康复者体内 T 细胞靶向的表位全景分析：荟萃分析、免疫流行率和网络平台。
Cell Rep Med. 2021 Jun 15;2(6):100312. doi: 10.1016/j.xcrm.2021.100312. Epub 2021 May 21.
6
SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 T cell activation in COVID-19 patients.SARS-CoV-2 全基因组 T 细胞表位图谱分析揭示了 COVID-19 患者中的免疫优势和大量 CD8+T 细胞激活。
Sci Immunol. 2021 Apr 14;6(58). doi: 10.1126/sciimmunol.abf7550.
7
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases.新冠病例中SARS-CoV-2表位的T细胞免疫显性和免疫流行率的综合分析。
Cell Rep Med. 2021 Feb 16;2(2):100204. doi: 10.1016/j.xcrm.2021.100204. Epub 2021 Jan 26.
Zotero 插件